Adenosine and Vascepa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Adenosine (adenosine) and Vascepa (icosapent ethyl). Common drug interactions include fatigue among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Adenosine and Vascepa. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Adenosine?

Adenosine has active ingredients of adenosine. eHealthMe is studying from 2,711 Adenosine users. Check the latest studies of Adenosine.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.

On Jul, 15, 2026

14 people who take Adenosine and Vascepa together, and have interactions are studied.

Adenosine and Vascepa drug interactions.

What are the common drug interactions of Adenosine and Vascepa, by gender? *:

female:

Fatigue (feeling of tiredness)
Anxiety
Back pain
Nausea (feeling of having an urge to vomit)
Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Back disorder
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac disorder
Decreased activity

male:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Hyperlipidaemia (presence of excess lipids in the blood)
Hypersensitivity
Multiple fractures
Muscle spasms (muscle contraction)
Radius fracture
Renal failure (kidney dysfunction)
Renal impairment (severely reduced kidney function)
Rib fracture

What are the common drug interactions of Adenosine and Vascepa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Decreased activity
Dysstasia (difficulty in standing)
Emotional distress
Fatigue (feeling of tiredness)
Gait disturbance
Immobile (not moving)
Impaired work ability
Intervertebral disc degeneration (spinal disc degeneration)

50-59:

Pain
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Bipolar disorder (mood disorder)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cellulitis (infection under the skin)
Depression
Emotional distress
Fatigue (feeling of tiredness)
Fracture

60+:

Back disorder
Back pain
Dyspnoea (difficult or laboured respiration)
Eye swelling
Fall
Fatigue (feeling of tiredness)
Heart rate increased
Immunisation reaction
Infusion related reaction
Nasopharyngitis (inflammation of the nasopharynx)

What are the existing conditions these people have? *

Hiv Infection: 4 people, 28.57%
Immunodeficiency Common Variable: 3 people, 21.43%
Primary Immunodeficiency Syndrome: 2 people, 14.29%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 14.29%
Lipodystrophy Acquired (a regional loss of subcutaneous adipose tissue which usually starts in the face, extends downward acquired): 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%
Dyskinesia (abnormality or impairment of voluntary movement): 1 person, 7.14%
Chest Pain: 1 person, 7.14%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Adenosine and Vascepa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously